Literature DB >> 30048945

Circulating Klotho levels can predict long-term macrovascular outcomes in type 2 diabetic patients.

Heng-Chih Pan1, Kuei-Mei Chou2, Chin-Chan Lee3, Ning-I Yang4, Chiao-Yin Sun5.   

Abstract

BACKGROUND AND AIMS: Type 2 diabetes is a global health problem that is associated with a wide variety of vascular complications and associated morbidity and mortality. Klotho is an enzyme and transmembrane protein, and increasing evidence suggests that Klotho may contribute to reduced oxidative stress, improved endothelial function, and vasoprotection. To date, the physiological role of Klotho in vascular complications associated with diabetes is unclear.
METHODS: We prospectively recruited 252 patients with type 2 diabetes, who visited an outpatient clinic at our hospital between 2009 and 2011. Patients in the top and bottom tertiles of circulating Klotho levels were enrolled for analysis.
RESULTS: Of the 168 patients enrolled, 45.8% were male, the mean age was 57.2 years, and the average duration of diabetes was 7.58 years. In multiple regression analysis, a high Klotho level was associated with a reduced risk of developing coronary artery disease and cerebrovascular accidents. Klotho level was also an independent predictor for the development of macroangiopathies within the 7-year study period.
CONCLUSIONS: Our results suggest that circulating Klotho level is a predictor of long-term macrovascular outcomes in patients with type 2 diabetes.
Copyright © 2018 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Circulating; Klotho; Long-term; Macroangiopathy; Type 2 diabetes; Vascular complication

Mesh:

Substances:

Year:  2018        PMID: 30048945     DOI: 10.1016/j.atherosclerosis.2018.07.006

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  12 in total

Review 1.  Klotho: An Elephant in Aging Research.

Authors:  Amin Cheikhi; Aaron Barchowsky; Amrita Sahu; Sunita N Shinde; Abish Pius; Zachary J Clemens; Hua Li; Charles A Kennedy; Joerg D Hoeck; Michael Franti; Fabrisia Ambrosio
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2019-06-18       Impact factor: 6.053

Review 2.  Biomarkers of vascular disease in diabetes: the adipose-immune system cross talk.

Authors:  Federico Biscetti; Elisabetta Nardella; Andrea Leonardo Cecchini; Andrea Flex; Raffaele Landolfi
Journal:  Intern Emerg Med       Date:  2020-01-09       Impact factor: 3.397

3.  Klotho expression in peripheral blood circulating cells is associated with vascular and systemic inflammation in atherosclerotic vascular disease.

Authors:  Ernesto Martín-Núñez; Atteneri Pérez-Castro; Víctor G Tagua; Carolina Hernández-Carballo; Carla Ferri; Nayra Pérez-Delgado; Sergio Rodríguez-Ramos; Purificación Cerro-López; Ángel López-Castillo; Alejandro Delgado-Molinos; Victoria Castro López-Tarruella; Miguel A Arévalo-Gómez; Ainhoa González-Luis; Alberto Martín-Olivera; Carmen Chaxiraxi Morales-Estévez; Carmen Mora-Fernández; Javier Donate-Correa; Juan F Navarro-González
Journal:  Sci Rep       Date:  2022-05-19       Impact factor: 4.996

4.  Soluble Klotho is associated with mortality and cardiovascular events in hemodialysis.

Authors:  Evangelos Memmos; Pantelis Sarafidis; Panagiotis Pateinakis; Apostolos Tsiantoulas; Danai Faitatzidou; Panagiotis Giamalis; Vassileios Vasilikos; Aikaterini Papagianni
Journal:  BMC Nephrol       Date:  2019-06-11       Impact factor: 2.388

Review 5.  Klotho: A Major Shareholder in Vascular Aging Enterprises.

Authors:  Kenneth Lim; Arvin Halim; Tzong-Shi Lu; Alan Ashworth; Irene Chong
Journal:  Int J Mol Sci       Date:  2019-09-19       Impact factor: 5.923

6.  Plasma Klotho concentration is associated with the presence, burden and progression of cerebral small vessel disease in patients with acute ischaemic stroke.

Authors:  Ho Geol Woo; Yoonkyung Chang; Dong-Ryeol Ryu; Tae-Jin Song
Journal:  PLoS One       Date:  2019-08-09       Impact factor: 3.240

7.  Association between serum levels of Klotho and inflammatory cytokines in cardiovascular disease: a case-control study.

Authors:  Ernesto Martín-Núñez; Javier Donate-Correa; Carla Ferri; Ángel López-Castillo; Alejandro Delgado-Molinos; Carolina Hernández-Carballo; Nayra Pérez-Delgado; Sergio Rodríguez-Ramos; Purificación Cerro-López; Víctor G Tagua; Carmen Mora-Fernández; Juan F Navarro-González
Journal:  Aging (Albany NY)       Date:  2020-01-27       Impact factor: 5.682

8.  S-Klotho level and physiological markers of cardiometabolic risk in healthy adult men.

Authors:  Agnieszka Żelaźniewicz; Judyta Nowak-Kornicka; Bogusław Pawłowski
Journal:  Aging (Albany NY)       Date:  2022-01-30       Impact factor: 5.682

9.  Klotho as a biomarker of subclinical atherosclerosis in patients with moderate to severe chronic kidney disease.

Authors:  Javier Donate-Correa; Carla M Ferri; Ernesto Martín-Núñez; Nayra Pérez-Delgado; Ainhoa González-Luis; Carmen Mora-Fernández; Juan F Navarro-González
Journal:  Sci Rep       Date:  2021-08-05       Impact factor: 4.379

Review 10.  Klotho and Mesenchymal Stem Cells: A Review on Cell and Gene Therapy for Chronic Kidney Disease and Acute Kidney Disease.

Authors:  Marcella Liciani Franco; Stephany Beyerstedt; Érika Bevilaqua Rangel
Journal:  Pharmaceutics       Date:  2021-12-21       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.